i-SEP - the alternative to allogeneic blood transfusions

21 Rue de la Noue Bras De Fer
44 200 NANTES
FRANCE

i-SEP is a French Medtech, based in Nantes (Upper Brittany, France) specialized in intraoperative cell salvage (IOCS) and Patient Blood Management (PBM) .
i-SEP has developed and patented an innovative technology for the separation of blood components.

Technology

same™

i-SEP is developing a new generation of intraoperative cell salvage technology (IOCS) for use in hemorrhagic or high-risk hemorrhagic surgery, capable of recovering not only red blood cells but also the patient's platelets.

Events & news

Chronicle

08.10.19

Radio: i-SEP interview by Europe 1 radio show (“innovation of the day”)

Surgery: the auto-transfusion of patients will soon be possible during operations. A French innovation to overcome platelet shortages and minimize the risks of conventional transfusions. The blood lost by the…

Event

13.09.19

SFAR 2019 Congress

[EVENT] Come meet us and discover our unique autotransfusion technology in the innovation space of the #SFAR2019 from September 19 to 21 in Paris. #PatientBloodManagement#SFAR#autotransfusion#BPIFrance

News

24.10.19

i-SEP raises €2.5 million for its innovative autotransfusion technology

i-SEP has raised a third round of funds of €2.5 million from its initial shareholders, including the venture capital fund Go Capital Amorçage, a group of business angels, and family…

All news

Expertise :
autotransfusion,
the alternative
to allogenic
transfusions

Learn more

Innovative solutions & efficiency for the patient

Technology

Events & news

Download a
press release